These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 18497953)

  • 1. The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation.
    Drebber U; Baldus SE; Nolden B; Grass G; Bollschweiler E; Dienes HP; Hölscher AH; Mönig SP
    Oncol Rep; 2008 Jun; 19(6):1477-83. PubMed ID: 18497953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and significance of cell cycle regulators in gastric carcinoma].
    Wu JF; Shao JC; Wang DB; Qin R; Zhang H
    Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of {beta}-catenin, MUC1 and c-met in diffuse-type gastric carcinomas: correlations with tumour progression and prognosis.
    Retterspitz MF; Mönig SP; Schreckenberg S; Schneider PM; Hölscher AH; Dienes HP; Baldus SE
    Anticancer Res; 2010 Nov; 30(11):4635-41. PubMed ID: 21115917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer.
    Wiksten JP; Lundin J; Nordling S; Kokkola A; Haglund C
    Anticancer Res; 2008; 28(4C):2279-87. PubMed ID: 18751407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
    Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
    J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
    Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
    J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
    Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
    Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
    Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological and immunohistochemical markers after radical gastrectomy for gastric cancer.
    Potrc S; Gadiijev E; Hajdinjak T; Kavalar R
    Hepatogastroenterology; 2007; 54(73):308-14. PubMed ID: 17419281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunohistochemical study of p21 and p53 expression in primary node-positive breast carcinoma.
    O'Hanlon DM; Kiely M; MacConmara M; Al-Azzawi R; Connolly Y; Jeffers M; Keane FB
    Eur J Surg Oncol; 2002 Mar; 28(2):103-7. PubMed ID: 11884043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer.
    Kim WB; Han HJ; Lee HJ; Park SS; Song TJ; Kim HK; Suh SO; Kim YC; Choi SY
    Ann Surg Oncol; 2009 Jan; 16(1):23-34. PubMed ID: 18979138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD24, p21, p53, and c-myc in alpha-fetoprotein-producing gastric cancer: Correlation with clinicopathologic characteristics and survival.
    Liu X; Yu H; Cai H; Wang Y
    J Surg Oncol; 2014 Jun; 109(8):859-64. PubMed ID: 24619835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of cell cycle-related molecules in gastric carcinoma: prognostic significance, correlation with clinicopathological parameters, proliferation and apoptosis.
    Lee KH; Lee HE; Cho SJ; Cho YJ; Lee HS; Kim JH; Nam SY; Chang MS; Kim WH; Lee BL
    Pathobiology; 2008; 75(6):364-72. PubMed ID: 19096232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
    Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
    Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinicopathologic significance of p53 and p21 expression in the surgical management of lingual squamous cell carcinoma.
    Yuen PW; Chow V; Choy J; Lam KY; Ho WK; Wei WI
    Am J Clin Pathol; 2001 Aug; 116(2):240-5. PubMed ID: 11488071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
    Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.
    Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
    Ann Surg Oncol; 2007 Oct; 14(10):2721-9. PubMed ID: 17564748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.